✦ LIBER ✦

A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma

✍ Scribed by Frances A. Shepherd; Lorne E. Rotstein; Sylvain Houle; Tsui-Chun K. Yip; Karen Paul; Kenneth W. Sniderman

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 489 KB
Volume: 70
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19921101)70:9<2250::aid-cncr2820700906>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I report of paclitaxel dose esca

A Phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma

✍ Frank R. Dunphy; James H. Boyd; Han J. Kim; Cherie H. Dunphy; Bruce R. Harrison; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Thirty-six patients with untreated Stage III/IV head and neck carcinoma were treated and were evaluable for toxicity. All patients had lesions that were

A Phase I dose escalation trial of conti

A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma

✍ Todd M. Zimmerman; David L. Grinblatt; Rebecca Malloy; Stephanie F. Williams 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## BACKGROUND. Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous infusion of paclitaxel to a previou

A phase I-II trial of mitoxantrone by he

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver

✍ Dennie V. Jones Jr.; Yehuda Z. Patt; Jaffer A. Ajani; James Abbruzzese; Bernard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

Phase I/II trial of paclitaxel by 1-hour

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to